SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE FISCAL YEAR ENDED					COMMISSION FILE NUMBER December 31, 1995								 0-12248 Daxor Corporation (Exact name of Registrant as specified in its charter) 	New York	 						13-2682108 (State or other jurisdiction of			 (IRS Employer incorporation or organization)			Identification Number) 350 Fifth Avenue Suite 7120 New York, New York 10118 (Address of principal executive offices) (Zip Code) Registrant's telephone number: (212) 244-0555 	Securities registered pursuant to Section 12(b) of the Act: 	Common Shares, $.01 par value 	(Title of Class) Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark whether Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. 					 Yes (X)			No ( ) Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-X is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this form 10-K. [ ] 	 As at March 28, 1996, the aggregate market value of the voting stock held by non-affiliates of the Registrant was $ 12,340,640. The market value of Common Stock of the Registrant, par value $.01 per share, was computed by reference to the closing price of one share on such date, as reported by the American Stock Exchange, which was $ 8.00. 	 The number of shares outstanding of the Registrant's Common Stock, par value $.01 per share, as of March 28, 1996: 4,722,709 shares. 	 Documents incorporated by reference: The information required by Part III is incorporated by reference from the proxy statement for the 1995 Annual Meeting of Shareholders. 	SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. 	DAXOR CORPORATION 			 	by: /s/ Joseph Feldschuh 	 Joseph Feldschuh, M.D. President and Chief 	 Executive Officer 	 Chairman of the Board 				 Dated: March 30, 1996 Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated. Signature Title Date /s/ Joseph Feldschuh President and Director March 30, 1996 Joseph Feldschuh, M.D. (Principal Executive Officer) /s/ Octavia Atanasiu Corporate Treasurer March 30, 1996 Octavia Atanasiu Accounting Supervisor	 (Principal Financial Officer) /s/ Stephen M. Moss Director March 30, 1996 Stephen M. Moss, PhD /s/ Veronica Schwendemann Director March 30, 1996 Veronica Schwendemann /s/ James Lombard Director March 30, 1996 James Lombard /s/ Martin Wolpoff Director March 30, 1996 Martin Wolpoff Board of Directors: 	Name			 Title Dr. Joseph Feldschuh	 Chairman, President, & CEO Stephen Moss		 Director James Lombard	 	Director Martin Wolpoff	 Director Veronica Schwendemann	 Director DAXOR CORPORATION Item 14(a) (1). Index to Financial Statements The following statements and schedules of Daxor Corporation are submitted herewith: 				 				 				 		Page Report of Independent Accountants................................... F-1 Financial Statements as at December 31, 1995 and 1994 and for the three years ended December 31, 1993 	Balance Sheets.................................... F-2 	Statements of Income.............................. F-3 	Statements of Shareholders' Equity................ F-3 	Statements of Cash Flows.......................... F-4 Notes to Financial Statements....................................... F-5 Schedule I - Marketable Securities - Other Investments - Year ended December 31, 1995................................................. F-9 Schedule IX - Short-term Borrowings - Years ended December 31, 1995 1994, and 1993.................................................... F-9 Schedule X - Supplementary Income Statement Information - Years ended December 31, 1995, 1994, and 1993....................... F-9 Exhibit - 27 Supplementary Exhibit as required by the Securities And Exchange Commission..................... Exhibit 1 All other schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are not required under the related instructions, are inapplicable or the required information is set forth in the financial statements filed herewith, including notes thereto, and therefore have been omitted.